Onward Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors (NCT05828459) | Onward Therapeutics | 2023-07-10 |
Track Onward Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.